维生素D缺乏与感染发生的相关性及其机制研究进展(5)
[14] GINDE AA，MANSBACH JM，CAMARGO CA. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey[J]. Arch Intern Med，2009，169(4)：384-390.
[15] ANTY R，TONOHOUAN M，FERRARI-PANAIA P，et al. Low levels of 25-hydroxy vitamin D are independently associated with the risk of bacterial infection in cirrhotic patients[J]. Clin Transl Gastroenterol，2014.DOI：10.1038/ctg.2014.6.
, 百拇医药
[16] PLETZ MW，TERKAMP C，SCHUMACHER U，et al. Vitamin D deficiency in community-acquired pneumonia：low levels of 1，25(OH)2D are associated with disease severity[J]. Respir Res，2014.DOI：10.1186/1465-9921-15- 53.
[17] PAREKH D，PATEL JM，SCOTT A，et al. Vitamin D deficiency in human and murine sepsis[J]. Crit Care Med，2017，45(2)：282-289.
[18] DE HAAN K，GROENEVELD AB，DE GEUS HR，et al. Vitamin D deficiency as a risk factor for infection，sepsis and mortality in the critically ill：systematic review and meta-analysis[J]. Crit Care，2014.DOI：10.1186/s13054- 014-0660-4.
, 百拇医药
[19] UPALA S，SANGUANKEO A，PERMPALUNG N. Significant association between vitamin D deficiency and sepsis：a systematic review and meta-analysis[J]. BMC Anesthesiol，2015.DOI：10.1186/s12871-015-0063-3.
[20] ABHIMANYU，COUSSENS AK. The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease[J]. Photochem Photobiol Sci，2017，16(3)：314-338.
[21] LIU PT，STENGER S，LI H，et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response[J]. Science，2006.DOI：10.1126/science.1123933.
, http://www.100md.com
[22] BAEKE F，KORF H，OVERBERGH L，et al. The vitamin D analog，TX527，promotes a human CD4+CD25highCD- 127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation[J]. J Immunol，2011，186(1)：132-142.
[23] XHINDOLI D，PACOR S，BENINCASA M，et al. The human cathelicidin LL-37-A pore-forming antibacterial peptide and host-cell modulator[J]. Biochim Biophys Acta，2016，1858(3)：546-566.
[24] GUO YJ，WANG L，LEI J，et al. Antimicrobial and antibiofilm activity of human cationic antibacterial peptide (LL-37) and its analogs against pan-drug-resistant acinetobacter baumannii[J]. Jundishapur J Microbiol，2017.DOI：10.5812/jjm.35857.
[25] MISHRA B，REILING S，ZARENA D，et al. Host defense antimicrobial peptides as antibiotics：design and application strategies[J]. Curr Opin Chem Biol，2017.DOI：10. 1016/j.cbpa.2017.03.014., 百拇医药(张晓丹 赵贝 李光慧 王斌 赵永红 黄仲义)
[15] ANTY R，TONOHOUAN M，FERRARI-PANAIA P，et al. Low levels of 25-hydroxy vitamin D are independently associated with the risk of bacterial infection in cirrhotic patients[J]. Clin Transl Gastroenterol，2014.DOI：10.1038/ctg.2014.6.
, 百拇医药
[16] PLETZ MW，TERKAMP C，SCHUMACHER U，et al. Vitamin D deficiency in community-acquired pneumonia：low levels of 1，25(OH)2D are associated with disease severity[J]. Respir Res，2014.DOI：10.1186/1465-9921-15- 53.
[17] PAREKH D，PATEL JM，SCOTT A，et al. Vitamin D deficiency in human and murine sepsis[J]. Crit Care Med，2017，45(2)：282-289.
[18] DE HAAN K，GROENEVELD AB，DE GEUS HR，et al. Vitamin D deficiency as a risk factor for infection，sepsis and mortality in the critically ill：systematic review and meta-analysis[J]. Crit Care，2014.DOI：10.1186/s13054- 014-0660-4.
, 百拇医药
[19] UPALA S，SANGUANKEO A，PERMPALUNG N. Significant association between vitamin D deficiency and sepsis：a systematic review and meta-analysis[J]. BMC Anesthesiol，2015.DOI：10.1186/s12871-015-0063-3.
[20] ABHIMANYU，COUSSENS AK. The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease[J]. Photochem Photobiol Sci，2017，16(3)：314-338.
[21] LIU PT，STENGER S，LI H，et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response[J]. Science，2006.DOI：10.1126/science.1123933.
, http://www.100md.com
[22] BAEKE F，KORF H，OVERBERGH L，et al. The vitamin D analog，TX527，promotes a human CD4+CD25highCD- 127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation[J]. J Immunol，2011，186(1)：132-142.
[23] XHINDOLI D，PACOR S，BENINCASA M，et al. The human cathelicidin LL-37-A pore-forming antibacterial peptide and host-cell modulator[J]. Biochim Biophys Acta，2016，1858(3)：546-566.
[24] GUO YJ，WANG L，LEI J，et al. Antimicrobial and antibiofilm activity of human cationic antibacterial peptide (LL-37) and its analogs against pan-drug-resistant acinetobacter baumannii[J]. Jundishapur J Microbiol，2017.DOI：10.5812/jjm.35857.
[25] MISHRA B，REILING S，ZARENA D，et al. Host defense antimicrobial peptides as antibiotics：design and application strategies[J]. Curr Opin Chem Biol，2017.DOI：10. 1016/j.cbpa.2017.03.014., 百拇医药(张晓丹 赵贝 李光慧 王斌 赵永红 黄仲义)